Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Cardiovascular Disease Physician in New Haven, CT
NPI: 1386827491Primary Practice Location
YALE-NEW HAVEN HOSPITAL
35 Park St, New Haven, CT
Primary Employer
Yale Medicine
yalemedicine.org
HQ Phone
Get M.D. John's Phone Numberphone_androidMobile
Get M.D. John's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCT State Medical License
Yale School of Medicine
medicine.yale.edu
Medical School
Until 2005
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 54 | 55 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 53 | 55 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 52 | 55 |
| 4 | 33361Replacement of aortic valve through the skin and femoral artery | 41 | 41 |
| 5 | 99152Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | 33 | 34 |
Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry.
Authors: Marc Pelletier, Guilherme Attizzani, Wilson Szeto
Publication Date: 2021-04-23
A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.
Authors: Kevin Abrams, Szilard Voros, Michael Cleman, Alexandra Lansky
Publication Date: 2015-08
2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
Authors: Jon Resar, Mubashir Mumtaz, Paul Teirstein, George Deeb, Paul Sorajja, Ronald Caputo, Hemal Gada, Joshua Rovin, Stanley Chetcuti, Ayman Iskander, Basel Ramlawi, William Merhi, Neal Kleiman, Abeel Mangi, Michael Reardon, Thomas Gleason, John Heiser, Douglas Spriggs, Steven Yakubov, Tanvir Bajwa
Journal: J Am Coll Cardiol
Lead Sponsor: Medtronic Cardiovascular
Intervention / Treatment: DEVICE: Edwards SAPIEN 3 or SAPIEN 3 Ultra THV Systems, DEVICE: Medtronic Evolut PRO, Evolut PRO+ or Evolut FX (where commercially available) TAV Systems
Lead Sponsor: Medtronic Cardiovascular
Intervention / Treatment: DEVICE: Evolut™ PRO and Evolut™ PRO+ System (Evolut™ FX System for the addendum)
Lead Sponsor: Medtronic Cardiovascular
Intervention / Treatment: DEVICE: Medtronic TAVR Systems
